Transcatheter heart-valve replacement: update

Transcatheter heart-valve replacement: update.

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

Update on transcatheter aortic valve replacement.

Transcatheter aortic valve replacement (TAVR) is currently the treatment modality of choice for patients with symptomatic severe aortic stenosis who are inoperable or at high risk for surgical aortic valve replacement. TAVR has shown a clear mortality benefit compared to conservative treatment in inoperable patients and is at least non-inferior to surgical aortic valve replacement in high-risk ...

Transcatheter Aortic Valve Replacement

With the worldwide number of TAVR procedures rapidly approaching 200,000, coupled with an amassed knowledge spanning over a decade, we are able to now reflect on the evolution of TAVR and how changes in technology, operator/institution experience, and patient selection have ultimately affected clinical outcomes. With this in mind, in this issue of JACC: Cardiovascular Interventions, Beohar et a...

Transcatheter Pulmonary Valve Replacement

Transcatheter pulmonary valve replacement (tPVR) has evolved into a viable alternative to surgical conduit or bioprosthetic valve replacement. This procedure has paved the way for a more advanced approach to congenital and structural interventional cardiology. Although many successes have been noted, there are still a number of challenges with this procedure, including large delivery systems, t...